InvestorsHub Logo
Followers 6
Posts 760
Boards Moderated 0
Alias Born 07/18/2006

Re: DewDiligence post# 12744

Wednesday, 11/26/2014 12:49:41 PM

Wednesday, November 26, 2014 12:49:41 PM

Post# of 20689
Dew, Teva submission seems to target Syntheon/Natco. Momenta a notable absence so delay of other generics by TEVA helps MNTA, no? Single product approval seems likely to me, at least short term. bp